Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 1, 2011, Pages 146-150

  Coleman, David ^a   Waddell, Simon J ^b   Mitchison, Denis A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

ATP availability; Low temperature; Pyrazinamide; TMC207

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; INCUBATION TEMPERATURE; LOW TEMPERATURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTITUBERCULAR AGENTS; COLD TEMPERATURE; HUMANS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS;

EID: 78650316560     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq414     Document Type: Article

References (21)

1. Hobby GL. The fate of tubercle bacilli in vivo. Am J Med 1955; 18: 753-63.
2. Hobby GL, Lenert TF. The in vitro action of antituberculosis agents against multiplying and non-multiplying microbial cells. Am Rev Tuberc Pulm Dis 1957; 76: 1031-48.
3. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistence. Infect Immun 1996; 64: 2062-9.
4. Betts JC, Lukey PT, Robb LC et al. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002; 43: 717-31.
5. Tudo G, Laing K, Mitchison DA et al. Examining the basis of isoniazid tolerance in non-replicating Mycobacterium tuberculosis using transcriptional profiling. Future Med Chem 2010; 2: 1371-83.
6. Garton NJ, Waddell SJ, Sherratt AL et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med 2008; 5: e75.
7. Rachman H, Strong M, Ulrichs T et al. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect Immun 2006; 74: 1233-42.
8. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003; 7: 6-21.
9. Gumbo T, Dona CS, Meek C et al. Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs. Antimicrob Agents Chemother 2009; 53: 3197-204.
10. Voskuil MI, Visconti KC, Schoolnik GK. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb) 2004; 84: 218-27.
11. Hampshire T, Soneji S, Bacon J et al. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? Tuberculosis (Edinb) 2004; 84: 228-38.
12. Andries K, Verhasselt P, Guillemont J et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005; 307: 223-7.
13. Diacon AH, Pym A, Grobusch M et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009; 360: 2397-405.
14. Mitchison DA, Ellard GA. 41. Antituberculosis drugs. In: Reeves DS, Phillips I, Williams JD, Wise R, eds. Laboratory Methods in Antimicrobial Chemotherapy. Edinburgh, London & New York: Churchill/Livingstone, 1978; 244-8.
15. Jindani A, Doré CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2002; 167: 1348-54.
16. Karakousis PC, Williams EP, Bishai WR. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis. J Antimicrob Chemother 2008; 61: 323-31.
17. Zhang Y, Wade MM, Scorpio A et al. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 2003; 52: 790-5.
18. Rao SP, Alonso S, Rand L et al. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2008; 105: 11945-50.
19. Boshoff HI, Barry CE III. Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol 2005; 3: 70-80.
20. Koul A, Vranckx L, Dendouga N et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 2008; 283: 25273-80.
21. Dhillon J, Andries K, Phillips PPJ et al. Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells. Tuberculosis (Edinb) 2010; 90: 301-5.